Viewing nowCombinationTeloduo Tablet 80/5 mg
Telmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.

MFDS item code 201907252 · Approved 2019.10.15 · Insurance code 648603860
Treatment of essential hypertension and dyslipidemia; prevention of cardiovascular disease and inhibition of atherosclerosis progression
This medication is used for patients who need to take telmisartan and rosuvastatin simultaneously. Telmisartan primarily treats essential hypertension and significantly reduces the risk of death from myocardial infarction, stroke, and cardiovascular diseases in high-risk patients aged 55 and older, especially in those where ACE inhibitors are unsuitable. Rosuvastatin is used as an adjunct when dietary control and exercise are insufficient for patients with primary hypercholesterolemia and mixed hyperlipidemia, lowering LDL cholesterol and delaying the progression of atherosclerosis. It also plays a role in reducing the risk of stroke, myocardial infarction, and arterial revascularization in patients with high-risk cardiovascular disease. Thus, this medication effectively improves cardiovascular disease risk by managing both hypertension and hyperlipidemia simultaneously.
In a drug interaction study of the active ingredients in this medicine, telmisartan 80mg and rosuvastatin 20mg, in the presence of rosuvastatin, the Cmax of telmisartan was approximately 0.87-fold and its AUC was approximately 1.00-fold; in the presence of telmisartan, the Cmax of rosuvastatin increased approximately 1.71-fold and its AUC increased approximately 1.16-fold. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and closely monitor the patient. This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan/rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is administered concomitantly with a thiazide diuretic such as hydrochlorothiazide, it provides an additional blood pressure-lowering effect. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. 3. Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
This medication can cause serious harm to the fetus and neonate during pregnancy, so administration must be stopped immediately if pregnancy is confirmed. This medication should not be administered to individuals allergic to its ingredients, pregnant or potentially pregnant women, nursing mothers, and those with severely impaired liver or kidney function. Patients with mildly impaired liver function, elderly patients, or those with high serum potassium levels need to exercise extra caution when using this medication. This medication can cause muscle problems, so if symptoms like muscle pain, weakness, or cramping occur, consult a doctor immediately. This medication can affect liver function, so regular liver function tests are necessary, and administration should be stopped if liver function deteriorates significantly. It has a blood pressure-lowering effect, so symptoms of hypotension may occur, especially in patients with reduced blood volume. This medication may interact with other drugs, so it is essential to strictly follow a doctor's instructions when used with potassium-sparing diuretics, potassium supplements, certain diuretics, immunosuppressants, etc. Patients at high risk for muscle damage should have their muscle enzyme levels checked before starting this medication and monitored regularly during therapy. Women who are pregnant or planning a pregnancy should not use this medication, and if pregnancy is confirmed during usage, they should stop taking it immediately. Safety and efficacy in children have not been established, so it is not recommended for use in this population. In cases of overdose, symptoms such as hypotension, dizziness, and acute kidney failure may occur, and immediate contact with a medical institution for appropriate treatment is required. Drowsiness or dizziness may occur during the use of this medication, so caution is needed when driving or operating hazardous machinery. This medication should be stored out of the reach of children and not transferred to other containers.
Headache, position-related dizziness, sleep paralysis, hypertension, hypotension, low blood pressure, elevated ALT, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver disorder, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, hives, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum CK, decreased hemoglobin, hypoglycemia, intravascular volume depletion, angioedema, shock, loss of consciousness, jaundice, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, inadequate efficacy, facial spasms, sensory anomalies, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, cough, indigestion, chest pain, myalgia, increased CK, constipation, increased AST, weakness, arthralgia, fatigue, numbness, chest discomfort, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a well-sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. Storing it this way will safely maintain the medication's effectiveness.
Bright pink oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.